























Abstract:Indirect treatment comparisons (ITCs) are essential in Health Technology Assessment (HTA) when head-to-head clinical trials are absent. A common challenge arises when attempting to compare a treatment with available individual patient data (IPD) against a competitor with only reported aggregate-level data (ALD), particularly when trial populations differ in effect modifiers. While methods such as Matching-Adjusted Indirect Comparison (MAIC) exist to adjust for these cross-trial differences, they are increasingly being superseded by regression-based marginalization methods. Historically, software implementations for these methods have often been fragmented or limited in scope. This article introduces outstandR, an R package designed to provide a comprehensive and unified framework for population-adjusted indirect comparison (PAIC). outstandR implements advanced G-computation methods - within both maximum likelihood and Bayesian frameworks, and Multiple Imputation Marginalization (MIM) to address non-collapsibility. By streamlining the workflow of covariate simulation, model standardization, and contrast estimation, outstandR enables robust and compatible evidence synthesis in complex decision-making scenarios.
From: Nathan Green Dr [view email]
[v1]
Mon, 12 Jan 2026 13:33:15 UTC (128 KB)
[v2]
Thu, 15 Jan 2026 15:36:18 UTC (127 KB)
[v3]
Tue, 9 Jun 2026 13:40:11 UTC (124 KB)
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。